Devonian Health Group Inc. (TSXV:GSD)
Canada · Delayed Price · Currency is CAD 12.40
0.00 (0.00%)
At close: Mar 18, 2026
Devonian Health Group Market Cap
Devonian Health Group has a market cap or net worth of CAD 34.3 million as of March 20, 2026. Its market cap has increased by 16.86% in one year.
Market Cap
34.30M
Enterprise Value
27.77M
Revenue
18.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.40
Market Cap Chart
Since May 19, 2017, Devonian Health Group's market cap has decreased from 1.44B to 34.30M, a decrease of -97.62%. That is a compound annual growth rate of -34.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 34.30M | 8.77% |
| Dec 24, 2025 | 31.53M | 32.95% |
| Dec 30, 2024 | 23.72M | 11.47% |
| Dec 21, 2023 | 21.28M | -52.33% |
| Dec 21, 2022 | 44.63M | -94.11% |
| Dec 31, 2021 | 758.36M | 359.02% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medicenna Therapeutics | 62.15M |
| NurExone Biologic | 56.11M |
| Sernova Biotherapeutics | 55.64M |
| MedMira | 45.33M |
| BriaCell Therapeutics | 44.88M |
| Defence Therapeutics | 44.60M |
| Microbix Biosystems | 34.56M |
| Resverlogix | 31.62M |